Why the study?
Does fenofibrate improve endothelial function and inflammatory markers in hypertriglyceridemic patients?
Population
10 hypertriglyceridemic patients
Comparison
Fenofibrate 200 mg daily for 3 months vs Baseline (before treatment)
Design
Cohort
Follow-up
3 months
Authors
Loading...
May improve endothelial function in hypertriglyceridemia; hypothesis-generating and requires randomized confirmation before practice change.
Does fenofibrate improve endothelial function and inflammatory markers in hypertriglyceridemic patients?
Fenofibrate improves fasting and post-prandial endothelial function and reduces inflammatory markers in patients with hypertriglyceridemia.
Marchesi et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: